Sana Biotechnology, Inc.

In the quarter to June 2026, EPS grew 43.6% and free cash flow fell 5.46%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

2.27 0.21 −8.47%

Follow SANA

Alert me

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(96.11%)	(118.70%)	(147.41%)	(152.87%)
ROA Full definition →		(47.13%)	(53.20%)	(59.09%)	(53.41%)
ROIC Full definition →		(394.10%)	(854.59%)	(1,115.75%)	0.00%
Return on Tangible Assets Full definition →		(150.09%)	(252.09%)	(473.57%)	(294.03%)
Free Cash Flow per Share Full definition →		(0.61)	(0.57)	(0.48)	(0.45)
Free Cash Flow Full definition →		(158.08)	(143.33)	(132.21)	(133.99)
Capital Expenditures Full definition →		0.27	0.49	0.34	(1.75)
Other line items
Cash ROIC Full definition →		(44.84%)	(47.23%)	(58.87%)	(41.97%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.68	0.59	0.55	0.62
Depreciation/Fixed assets Full definition →		0.45	0.47	0.45	0.43
Capex/Depreciation Full definition →		0.02	0.04	0.03	(0.16)
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.61)	(0.57)	(0.48)	(0.45)
Capex per Share Full definition →		0.00	0.00	0.00	(0.01)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Columns are period end dates